Disease Control in RRMS Transferring Treatment From Natalizumab to Fingolimod

Clinical trial NCT02277964 · COMPLETED

Trial details

NCT number: NCT02277964
Sponsor: University Hospital, Basel, Switzerland
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2012-03-01
Primary completion: 2016-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.